IKBKG Gene

IKBKG Gene (NF-κB Essential Modulator / NEMO)

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">IKBKG Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>IKBKG</td></tr>
<tr><td><strong>Full Name</strong></td><td>IκB Kinase Gamma / NEMO</td></tr>
<tr><td><strong>Chromosome</strong></td><td>Xq28</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[8517](https://www.ncbi.nlm.nih.gov/gene/8517)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[300300](https://omim.org/entry/300300)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>[ENSG00000265203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y6K9](https://www.uniprot.org/uniprot/Q9Y6K9)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>419 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~48 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Incontinentia Pigmenti, IP, NEMO deficiency, X-linked EDA-ID</td></tr>
<tr><td><strong>Aliases</strong></td><td>NEMO, IP, FIP-3, IKKγ</td></tr>
</table>
</div>

IKBKG Gene (NF-κB Essential Modulator / NEMO)

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">IKBKG Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>IKBKG</td></tr>
<tr><td><strong>Full Name</strong></td><td>IκB Kinase Gamma / NEMO</td></tr>
<tr><td><strong>Chromosome</strong></td><td>Xq28</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[8517](https://www.ncbi.nlm.nih.gov/gene/8517)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[300300](https://omim.org/entry/300300)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>[ENSG00000265203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y6K9](https://www.uniprot.org/uniprot/Q9Y6K9)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>419 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~48 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Incontinentia Pigmenti, IP, NEMO deficiency, X-linked EDA-ID</td></tr>
<tr><td><strong>Aliases</strong></td><td>NEMO, IP, FIP-3, IKKγ</td></tr>
</table>
</div>

IKBKG (IκB Kinase Gamma), also known as NEMO ([NF-κB](/entities/nf-kb) Essential Modulator), encodes a critical regulatory subunit of the IκB kinase (IKK) complex. The IKK complex consists of IKKα, IKKβ, and IKKγ (NEMO) and is essential for activating the NF-κB signaling pathway, one of the most important transcription factor systems in mammalian cells[@rothwarf1998][@yamaoka1998].

IKBKG is critical for immune responses, inflammation, cell survival, and development. Mutations in IKBKG cause Incontinentia Pigmenti (IP), an X-linked dominantly inherited disorder characterized by skin lesions, neurological manifestations, and ocular abnormalities. In the brain, NEMO regulates [neuroinflammation](/mechanisms/neuroinflammation) and [neuronal survival](/cell-types/neurons), making it a key player in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@israel2010][@liu2017].

Gene Structure and Evolution

Genomic Organization

The IKBKG gene is located on the X chromosome at position Xq28 and spans approximately 44 kb. The gene consists of 23 coding exons that generate a 2.5 kb mRNA transcript encoding a 419-amino acid protein. The gene is highly conserved across mammals, with orthologs identified in mice, rats, and other vertebrates[@hyde2020].

Protein Domain Architecture

The NEMO protein contains several functional domains:

The protein forms a homodimer that serves as the scaffold for assembly of the IKK complex. NEMO specifically binds to the C-terminal region of both IKKα and IKKβ through its NBD, bringing these catalytic subunits together[@gjisat2010].

The IKK Complex

Complex Composition

The IκB kinase (IKK) complex is a critical signaling hub consisting of:

• IKKα (IKBKΑ): IKK1, a serine/threonine kinase with nuclear functions
• IKKβ (IKBKB): IKK2, the primary kinase for NF-κB activation
• IKKγ/NEMO: Regulatory subunit essential for complex assembly and activation

NEMO's Role in the IKK Complex

NEMO functions as the essential regulatory subunit through multiple mechanisms[@hacker2013]:

Complex Assembly: NEMO serves as the scaffold that brings IKKα and IKKβ together, stabilizing the complex and enabling efficient kinase activation.

Signal Integration: NEMO receives signals from multiple upstream receptors including:

• Toll-like receptors (TLRs)
• Cytokine receptors (IL-1R, TNFR)
• T-cell and B-cell receptors
• Pattern recognition receptors

IKK Activation Mechanism

The activation of the IKK complex follows a well-characterized pathway:

Biological Functions

Immune Response

NEMO is essential for innate and adaptive immune responses[@kawai2019]:

Innate Immunity:

• TLR signaling: NEMO is required for signaling through all TLRs
• RIG-I-like receptor signaling: Cytoplasmic RNA/DNA sensing
• Cytokine signaling: IL-1R, IL-18R, TNFR family signaling

• T-cell receptor (TCR) signaling: NF-κB activation in T cells
• B-cell receptor (BCR) signaling: B cell activation and survival
• Cytokine production: Production of IL-2, IL-6, TNF-α

Cell Survival

The [NF-κB](/entities/nf-kb) pathway activated by NEMO is a major pro-survival signaling cascade:

• Anti-apoptotic gene expression (Bcl-2, Bcl-xL, c-IAPs)
• Cellular stress response
• DNA damage response
• Metabolic regulation

Development

NEMO is crucial for embryonic development:

• Embryonic lethal in mice without functional NEMO
• Defects in limb development, hair formation, and immune system
• Critical for ectodermal development

Role in Neurodegeneration

Alzheimer's Disease

NEMO plays a complex role in AD pathogenesis through [NF-κB](/entities/nf-kb)-mediated neuroinflammation[@mattson2007][@singh2012]:

Neuroinflammation:

• Aβ oligomers activate NF-κB through NEMO in microglia and neurons
• Chronic NF-κB activation drives pro-inflammatory cytokine production
• Creates a feed-forward loop of neuroinflammation and neuronal damage

• NEMO is expressed in neurons throughout the brain
• NF-κB regulates synaptic plasticity and memory-related genes
• Dysregulated NEMO signaling contributes to synaptic dysfunction

• IKKβ inhibitors reduce neuroinflammation in AD models
• Anti-inflammatory strategies targeting NEMO/NF-κB pathway
• Modulation of NEMO may protect against Aβ toxicity

Parkinson's Disease

In PD, NEMO-mediated [NF-κB](/entities/nf-kb) activation contributes to dopaminergic neuron degeneration[@arruda2014]:

Microglial Activation:

• Activated microglia in substantia nigra show high NEMO activity
• NF-κB-driven inflammatory cytokines (TNF-α, IL-1β, IL-6) are elevated
• Contributes to progressive dopaminergic neuron loss

• α-Synuclein aggregates can activate NF-κB via NEMO
• Mitochondrial dysfunction triggers NEMO-dependent cell death
• Oxidative stress amplifies NEMO/NF-κB activation

• IKK inhibitors protect dopaminergic neurons in models
• Anti-inflammatory approaches reduce microglial activation
• NEMO modulators may slow disease progression

Stroke and Ischemic Injury

NEMO plays a dual role in ischemic stroke[@wang2018][@li2023]:

Acute Phase:

• Ischemia rapidly activates NEMO/NF-κB pathway
• NF-κB drives expression of inflammatory mediators
• Contributes to excitotoxic and inflammatory damage

• Later NF-κB activation promotes inflammatory resolution
• Contributes to tissue remodeling and repair
• Timing of intervention critical for outcome

Other Neurodegenerative Conditions

NEMO dysfunction has been implicated in:

Amyotrophic Lateral Sclerosis (ALS):

• Activated microglia in spinal cord show elevated NEMO
• NF-κB contributes to motor neuron death
• Therapeutic targeting under investigation

• Demyelinating lesions show NEMO activation
• Contributes to oligodendrocyte damage
• NF-κB blockade may be protective

• Mutant huntingtin activates NEMO/NF-κB
• Contributes to neuronal dysfunction
• Inflammatory component of disease pathogenesis

Structure-Function Relationships

NEMO Domains and Their Functions

| Domain | Location | Function | Disease Relevance |
|--------|----------|-----------|-------------------|
| NBD | N-terminus | IKKα/β binding | Essential for function |
| Coiled-coil 1 | aa 85-200 | Dimerization, upstream signal sensing | Mutations cause IP |
| Leucine zipper | aa 250-340 | Protein interactions | Ubiquitin binding |
| Zinc finger | aa 370-400 | Linear ubiquitin recognition | Critical for activation |

Mutations and Disease

Over 200 pathogenic mutations in IKBKG have been identified[@bonif2019]:

Incontinentia Pigmenti (IP):

• X-linked dominant, embryonic lethal in males (except mosaic)
• Characteristic skin lesions (whorled hyperpigmentation)
• Neurological manifestations (seizures, intellectual disability)
• Ocular abnormalities (retinal detachment)

• X-linked recessive, hypomorphic mutations
• Ectodermal dysplasia (sparse hair, missing teeth)
• Immunodeficiency (susceptibility to infections)
• Variable neurological involvement

Therapeutic Implications

Targeting the NEMO/NF-κB Pathway

The NEMO/NF-κB pathway represents a therapeutic target in neurodegeneration[@chen2022]:

IKK Inhibitors:

• IKKβ inhibitors reduce neuroinflammation
• Examples: MLN120B, Bay 11-7082
• Challenges: systemic immunosuppression

• Peptide inhibitors of NEMO interactions
• Small molecules modulating NEMO ubiquitination
• Gene therapy approaches (under development)

• NF-κB DNA-binding inhibitors
• Antioxidants reducing oxidative stress
• Anti-inflammatory compounds

Biomarker Potential

NEMO pathway activity may serve as a biomarker:

• NF-κB target gene expression in peripheral blood cells
• Phosphorylation status of IKK in cerebrospinal fluid
• Imaging of neuroinflammation using PET ligands

Expression Pattern

Tissue Distribution

IKBKG is ubiquitously expressed with highest levels in:

• Immune organs (spleen, thymus, lymph nodes)
• Brain (cortex, hippocampus, cerebellum)
• Peripheral immune cells (T cells, B cells, macrophages)

Cellular Expression

In the brain, NEMO is expressed in:

• Neurons: Throughout cortex, hippocampus, basal ganglia
• Astrocytes: Reactive astrocytes show elevated NEMO
• Microglia: High baseline expression, further increased with activation
• Oligodendrocytes: Lower expression, may increase in disease

Signaling Pathways

Cross-References

• [IKBKG Protein](/proteins/ikbkg-protein)
• [IKBKB Gene](/genes/ikbkb)
• [IKK Complex Proteins](/proteins/ikk-complex)
• [NF-κB Signaling Pathway](/mechanisms/nf-kappa-b-signaling)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Microglia](/cell-types/microglia)

Research Directions

Key Unresolved Questions

Emerging Research Areas

• Single-cell analysis of NEMO pathway in neurodegenerative brain
• Development of brain-penetrant IKK inhibitors
• Gene therapy approaches targeting NEMO
• Combination therapies addressing multiple pathways

Clinical Genetics

Genetic Testing

IKBKG testing is available for:

• Confirmation of clinical diagnosis of IP
• Carrier testing for female relatives
• Prenatal diagnosis in families with known mutation
• Newborn screening in some populations

Genotype-Phenotype Correlation

The specific IKBKG mutation correlates with:

• Severity of skin involvement
• Presence of neurological manifestations
• Immune dysfunction
• Response to treatment

External Links

• NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/8517](https://www.ncbi.nlm.nih.gov/gene/8517)
• OMIM: [https://omim.org/entry/300300](https://omim.org/entry/300300)
• Ensembl: [https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203)
• UniProt: [https://www.uniprot.org/uniprot/Q9Y6K9](https://www.uniprot.org/uniprot/Q9Y6K9)
• Incontinentia Pigmenti Foundation: [https://www.ipfdu.org/](https://www.ipfdu.org/)

References

See Also

• [Riluzole ALS Trials](/wiki/clinical-trials-riluzole-als) — activates
• [Riluzole ALS Trials](/wiki/clinical-trials-riluzole-als) — regulates
• [HMGB1 — High Mobility Group Box 1](/wiki/genes-hmgb1) — expressed_in
• [IKBKB Gene](/wiki/genes-ikbkb) — expressed_in
• [IKBKB Gene](/wiki/genes-ikbkb) — interacts_with

Pathway Diagram

The following diagram shows the key molecular relationships involving IKBKG Gene discovered through SciDEX knowledge graph analysis: